SGP

US$20.76

Price alerts

Get one email when SGP crosses your level. Checked every 15 minutes during market hours.

▲ +0.16 (0.78%)up today

Open: US$20.17
High: US$21.53
Low: US$20.17
Prev close: US$20.60

USD · data via Finnhub · delayed/cached up to 1–5 min

Technicals

RSI (14-day)

52.7

Neutral

Above 70 can signal overbought; below 30, oversold.

MACD

0.14

Bullish momentum

MACD above its signal line (0.00).

50-day average

20.56

Price above

Short-term trend reference.

Daily values · indicators are descriptive, not trading advice

About SpyGlass Pharma, Inc.

Healthcare · Biotechnology

SpyGlass Pharma, Inc. is a late-stage biopharmaceutical company specializing in sustained drug delivery solutions for chronic eye conditions, particularly open-angle glaucoma and ocular hypertension. Founded in 2019 by Malik Y. Kahook, M.D., and Glenn Sussman, the company develops innovative platforms that integrate approved medicines like bimatoprost into familiar surgical procedures to provide long-term disease control and vision preservation. Its lead candidate, the BIM-IOL System, combines p…

www.spyglasspharma.com

Key metrics

Market cap: $689M
P/B: 3.46
52-week high: 32.44
52-week low: 17.06
Return on equity: -75.4%
Beta: 0.75
YTD return: -22.0%

Analyst recommendations

5 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-07-01)
5 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-06-01)
5 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-05-01)
5 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-04-01)

Earnings (EPS)

Quarter	Estimate	Actual	Result
2026-06-09	0.48	0.22	✗ Miss
2026-05-14	-0.36	-0.69	✗ Miss
2026-04-10	-0.16	-0.14	✓ Beat

Similar stocks

Companies in the same industry, via Finnhub

AI research for SGP

Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.

Analyze SGP with AI →